Navigation Links
Neurologix Completes Additional $7 Million Financing
Date:12/6/2010

ny. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, or performance, as well as underlying assumptions and statements that are other than statements of historical fact. When used in this document, the words "expects," "promises," "anticipates," "estimates," "plans," "intends," "projects," "predicts," "believes," "may" or "should," and similar expressions, are intended to identify forward-looking statements. These statements reflect the current view of the Company's management with respect to future events. Many factors could cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, but not limited to, the following:

  • The Company is still in the development stage and has not generated any revenues. From inception through September 30, 2010, it incurred net losses and negative cash flows from operating activities of approximately $58 million and $43 million respectively. Management believes that the Company will continue to incur net losses and cash flow deficiencies from operating activities for the foreseeable future. Because it may take years to develop, test and obtain regulatory approval for a gene-based therapy product before it can be sold, the Company likely will continue to incur significant losses for the foreseeable future. Accordingly, it may never be profitable and, if it does become profitable, it may be unable to sustain profitability.
  • The Company will need to conduct future clinical trials for treatment of Parkinson's disease using NLX-P101. If the trials prove unsuccessful, future operations and the potential for profitability will be materially adversely affected and the business may not succeed.
  • There is no assurance as to when, or if, the Company will be able to successfully re
    '/>"/>

  • SOURCE Neurologix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
    2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
    3. Neurologix Reports Third Quarter 2010 Financial Results
    4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
    10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
    11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The global ... of products, methods, applications, end users, and geographies. ... in the microbial identification market. This favorable growth ... (per test) and the time required for microbial ... technological advancements. Furthermore, genotypic methods have high applications ...
    (Date:7/29/2014)... Calif., July 29, 2014 Amgen (NASDAQ: ... second quarter of 2014. Key results include: , ... 8 percent product sales growth driven by strong performance ... ® (carfilzomib), Prolia ® (denosumab) and XGEVA ... percent to $2.37, driven by higher revenues and a ...
    (Date:7/29/2014)... 29, 2014  Express Scripts Holding Company (Nasdaq: ... attributable to Express Scripts stockholders of $515.2 million, or ... as detailed in Table 4, was $1.23 for the ... positioned to serve our clients with scale, alignment and innovative ... the health outcomes of our members," stated George Paz, chairman ...
    Breaking Medicine Technology:Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7
    ... 2011 Reportlinker.com announces that a new ... catalogue: Global Blood Pressure ... http://www.reportlinker.com/p092555/Global-Blood-Pressure-Monitoring--Measurement-Instruments-Industry.html ... Blood Pressure Measurement Instruments in US$ Million ...
    ... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Medical ... This report analyzes the worldwide ... by the following segments: Oxygen Concentrators, Liquid Oxygen ...
    Cached Medicine Technology:Global Blood Pressure Monitoring & Measurement Instruments Industry 2Global Blood Pressure Monitoring & Measurement Instruments Industry 3Global Blood Pressure Monitoring & Measurement Instruments Industry 4Global Blood Pressure Monitoring & Measurement Instruments Industry 5Global Blood Pressure Monitoring & Measurement Instruments Industry 6Global Blood Pressure Monitoring & Measurement Instruments Industry 7Global Blood Pressure Monitoring & Measurement Instruments Industry 8Global Blood Pressure Monitoring & Measurement Instruments Industry 9Global Blood Pressure Monitoring & Measurement Instruments Industry 10Global Blood Pressure Monitoring & Measurement Instruments Industry 11Global Blood Pressure Monitoring & Measurement Instruments Industry 12Global Blood Pressure Monitoring & Measurement Instruments Industry 13Global Blood Pressure Monitoring & Measurement Instruments Industry 14Global Blood Pressure Monitoring & Measurement Instruments Industry 15Global Blood Pressure Monitoring & Measurement Instruments Industry 16Global Blood Pressure Monitoring & Measurement Instruments Industry 17Global Blood Pressure Monitoring & Measurement Instruments Industry 18Global Blood Pressure Monitoring & Measurement Instruments Industry 19Global Blood Pressure Monitoring & Measurement Instruments Industry 20Global Blood Pressure Monitoring & Measurement Instruments Industry 21Global Blood Pressure Monitoring & Measurement Instruments Industry 22Global Blood Pressure Monitoring & Measurement Instruments Industry 23Global Blood Pressure Monitoring & Measurement Instruments Industry 24Global Blood Pressure Monitoring & Measurement Instruments Industry 25Global Blood Pressure Monitoring & Measurement Instruments Industry 26Global Medical Oxygen Systems Industry 2Global Medical Oxygen Systems Industry 3Global Medical Oxygen Systems Industry 4Global Medical Oxygen Systems Industry 5Global Medical Oxygen Systems Industry 6Global Medical Oxygen Systems Industry 7Global Medical Oxygen Systems Industry 8Global Medical Oxygen Systems Industry 9Global Medical Oxygen Systems Industry 10Global Medical Oxygen Systems Industry 11
    (Date:7/29/2014)... Many people complain about their dependence on eyeglasses. For many, ... on glasses to see their clock or make their way ... dissatisfied with their vision even when using their glasses because ... especially at night due to glare. They can make ... the TV, sew or cross stitch, or read fine print. ...
    (Date:7/29/2014)... Thompson HealthDay Reporter , TUESDAY, ... and good sleep can protect the body against the negative ... a cellular level, researchers report. A study involving hundreds ... increased shortening of telomeres, the protective caps at the ends ... found that over a one-year period, the more stressors a ...
    (Date:7/29/2014)... receive steady follow-up care, the living donors themselves ... care more accessible, UC San Francisco and Walgreens ... the first program in the country that provides ... kidney donors. , UCSF will provide vouchers for ... Walgreens pharmacies and Healthcare Clinic at select Walgreens ...
    (Date:7/29/2014)... Asheville, NC (PRWEB) July 29, 2014 Most ... like to look younger and feel better about their appearance. ... body work too in Asheville, NC that can help ... a skin care salon specializing in result oriented anti-aging procedures ... help the stubborn problem so many have with cellulite. ...
    (Date:7/29/2014)... Helping people recover from the debilitating effects ... requires deep knowledge of neurophysiology as well as effective ... outcomes has been the primary focus of research by ... joined the NJIT faculty more than a decade ago. ... funding from sources such as the National Institutes of ...
    Breaking Medicine News(10 mins):Health News:Cataract Surgery: New Technology for Reduced Dependence on Glasses 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 2Health News:Healthy Habits May Slow Cellular Signs of Aging, Study Finds 3Health News:Caring for donors 2Health News:Caring for donors 3Health News:Supreme Skin Announces Plans for a Grand Re-opening for Their Noninvasive Anti Aging Microcurrent Face and Body Treatments In Asheville, NC 2Health News:Continuing the Quest for Better Stroke Therapies 2Health News:Continuing the Quest for Better Stroke Therapies 3Health News:Continuing the Quest for Better Stroke Therapies 4
    ... A UCSF/San Francisco General Hospital project that used a ... patients was honored recently with a quality leadership award ... The Institute, the quality improvement partner of the California ... Quality Leaders Award to innovative programs within California,s public ...
    ... of researchers from the University of Vigo, Rutgers University ... the United Kingdom, has developed "laser spinning", a novel ... been able to manufacture bioglass nanofibres, the bioactive glass ... "Laser spinning makes it possible to produce glass nanofibres ...
    ... God, affects medical choices, study finds , FRIDAY, Dec. 18 (HealthDay ... could be just as important as taking care of their medical ... was important to them at the end of their lives, people ... at peace with God, the study found. , "Medicine tends ...
    ... ... the nostrils help deliver scent molecules into the nose to the olfactory bulb, where ... From there, they are forwarded to areas of the central nervous system that mediate ... ...
    ... Test & ... ... -- Applied Predictive Technologies (APT) announced today that Banfield, The Pet Hospital ... Test & Learn Management System. Banfield, which treats more than 5 million pets per year ...
    ... ... R. Raval, MD FACS is offering gift certificates and his own name-brand prescription-strength line of ... ... Christmas, chances are you need help get your shopping done! Online gift certificates are now ...
    Cached Medicine News:Health News:UCSF/SFGH project for diabetes patients wins award for innovation, quality 2Health News:Spiritual Needs Rank High as Death From Cancer Nears 2Health News:Spiritual Needs Rank High as Death From Cancer Nears 3Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 2Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 3Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 4Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 5Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 6Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 7Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 8Health News:Adoodle Announces New Advisory Board and Readies the Launch of the New NOXO Behavioral Modification Products 9Health News:Banfield, The Pet Hospital Signs Agreement to License APT's Test & Learn Management System 2Health News:Banfield, The Pet Hospital Signs Agreement to License APT's Test & Learn Management System 3Health News:Streamline Your Holiday Shopping With Online Savings At Ravalmd.com 2
    ... Special Protective Apron is made to ... a sterile gown. Uniquely it can ... field. Reaching through the back of ... released, and the protective apron will ...
    Wolfs unique apron and vest set distributes weight evenly between shoulders and hips. The vest comes with an attached Thyroid collar - .5mm lead equivalency protection front, 5mm back....
    ... Wolfs Easy Wrap Apron has always been ... to put-on, adjust and take-off. Our new ... Easy sures Wrap features two velcro closures ... attached Thyroid collar adjusted to fully protect ...
    The O.R. Special Protective Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is availa...
    Medicine Products: